Blood Cell Score for Identifying Aggressive Melanoma

Source: Cancer Therapy Advisor, March 2021

Researchers have established a myeloid index score (MIS) that identified patients with melanoma with more aggressive disease, according to the results of their study published in the Journal for ImmunoTherapy of Cancer.

Use of the score may help to tailor therapeutic choices for patients at higher risk of aggressive melanoma.

READ THE ORIGINAL FULL ARTICLE